Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 192


Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 

    Article Cited by others


A study evaluating the effect of mifepristone (RU-486) for the treatment of leiomyomata uteri

Mukherjee Sucheta, Chakraborty Somajita

Year : 2011| Volume: 52| Issue : 3 | Page no: 150-152

   This article has been cited by
1 A randomized control trial to assess efficacy of Mifepristone in medical management of uterine fibroid
D. Arora,Jaya Chawla,S.P.S. Kochar,J.C. Sharma
Medical Journal Armed Forces India. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Efficacy of Use of Long-Term, Low-Dose Mifepristone for the Treatment of Fibroids
Anupam Kapur,Ranjeeta Angomchanu,Madhusudan Dey
The Journal of Obstetrics and Gynecology of India. 2016;
[Pubmed]  [Google Scholar] [DOI]
3 Selective progesterone receptor modulators: an update
Giuseppe Benagiano,Carlo Bastianelli,Manuela Farris,Ivo Brosens
Expert Opinion on Pharmacotherapy. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study
Gil M. Yerushalmi,Yinon Gilboa,Ariella Jakobson-Setton,Yona Tadir,Chen Goldchmit,Danny Katz,Daniel S. Seidman
Fertility and Sterility. 2013;
[Pubmed]  [Google Scholar] [DOI]
5 Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis
Qi Shen,Ying Hua,Wenxiao Jiang,Wenwen Zhang,Miaomiao Chen,Xueqiong Zhu
Fertility and Sterility. 2013;
[Pubmed]  [Google Scholar] [DOI]


Read this article